Skip to content

Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 1

Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 1

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02179034
Enrollment
59
Registered
2014-07-01
Start date
2014-10-23
Completion date
2017-06-12
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nicotine Dependence, Other Tobacco Product

Keywords

tobacco, electronic cigarettes, menthol, flavors

Brief summary

This study is to examine if inhaled doses of menthol that produce low and high cooling effects change the appeal of e-cigarettes containing low and high doses of nicotine in adolescent smokers. The hypothesis is that the combination of nicotine and menthol, when compared with menthol or nicotine alone, will result in greater increase in liking of an e-cigarette and greater reduction in nicotine withdrawal.

Interventions

DRUGNicotine

Participants will receive no nicotine, low dose nicotine (6 mg/ml) or high dose nicotine (12 mg/ml)

OTHERLow Dose Menthol

A low dose of menthol will be added to the tobacco flavor.

OTHERHigh Dose Menthol

A high dose of menthol will be added to the tobacco flavor.

Sponsors

Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 20 Years
Healthy volunteers
Yes

Inclusion criteria

* Ages 18-20 years * Able to read and write * Cigarette smoker * Use of e-cigarettes in the past 30 days

Exclusion criteria

* Seeking smoking cessation treatment * Current/lifetime criteria for dependence on another psychoactive substance -Daily use of alcohol or marijuana or use of any other drugs including cocaine, opiates, stimulants * Regular use of psychoactive drugs including anxiolytics, antidepressants and other psychostimulants * Current or past history of psychosis or other psychiatric diagnosis such as major depression * Any significant current medical condition

Design outcomes

Primary

MeasureTime frameDescription
Liking/effect score of the e-cigaretteEvery 30 min for 120 min during lab sessionThe Drug Effects Questionnaire (Soria et al) will be used to ask about participants' liking/effect of the e-cigarettes smoked during the 4 bouts of e-cigarette puffing during the lab session to determine which menthol dose is most preferred. A linear mixed-effects regression model wil be used with nicotine group (none, low, high) as between-subject factor, and menthol dose (none, low dose, high dose) as within-subject factor.

Secondary

MeasureTime frameDescription
Maximum value of money at which the e-cigarette is chosen over moneyEvery 30 min for 120 min during lab sessionE-cigarette value will be determined using the Multiple Choice Procedure (Griffiths et al, 1993) to determine the reinforcing value of the e-cigarette. The MCP involves sampling the e-cigarette and then making a discrete choice between the e-cigarette or a series of monetary values.
Change scores from baseline in Nicotine WithdrawalEvery 30 min for 120 min during lab sessionThe Minnesota Nicotine Withdrawal Scale (Hughes et al,1986) will be used to assess the magnitude of change in nicotine withdrawal symptoms during the lab session
Change scores from baseline in Tobacco CravingEvery 30 min for 120 min during lab sessionThe Brief Questionnaire on Smoking Urges (Tiffany & Drobes,1991) will be used to assess the magnitude of change in tobacco craving during the lab session

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026